Merck Mercuriadis to step away from Hipgnosis Song Management
Founder and chair will step away upon completion of Hipgnosis Song Fund’s sale to Blackstone
Hipgnosis Song Fund
-
-
Concord Music will not improve $1.51bn Hipgnosis bid
Following Blackstone’s $1.57bn counter offer
-
Blackstone launches £1.2bn rival bid for Hipgnosis Songs
Trust’s board said it would be minded to recommend the proposal to shareholders if a firm offer was made
-
Hipgnosis hit with 26.3% reduction to portfolio valuation
NAV per share falls to $1.17 from $1.74 after independent valuation
-
Hipgnosis shareholders back £20m offer to prospective buyers
99.9% of those who attended the EGM voted in favour
-
Hipgnosis seeks indemnity from founder amid legal claims
While Mercuriadis has stood down as CEO of the trust’s investment adviser
-
Hipgnosis offers £20m to entice prospective bidders
Investment adviser’s call option a ‘structural conflict’, the trust’s board said
-
Hipgnosis reports 9.2% NAV drop as it narrowly beats results deadline
Driven by a reduction in the fair value of the portfolio
-
Hipgnosis delays interim results over valuation concerns
Board raised concerns over independent valuer’s appraisal of the trust’s portfolio
-
Hipgnosis and founder hit with legal claim over alleged ‘diversion of opportunity’
Claim made by Hipgnosis Music Limited
-
Hipgnosis appoints former Round Hill directors to board
Robert Naylor named chair, while Francis Keeling appointed NED
-
Hipgnosis scraps dividend until new financial year
Hipgnosis’s catalogue bonus provision is expected to increase by £18.5m to £54.8m
